Clinical Trial: A Clinical Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Administered Beyond Release Criteria in Subjects with Relapsed/Refractory B‑Cell Non‑Hodgkin Lymphoma (China)

China, Aug. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Clinical Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Administered Beyond Release Criteria in Subjects with Relapsed/Refractory B‑Cell Non‑Hodgkin Lymphoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130915

Registration Time: 2026/08/26

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Soochow University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338119

Published by HT Digital Content Services with permission from Health Daily Digest....